open access
The Urogynecology Section of the Polish Society of Gynecologists and Obstetricians Guideline on the use of urodynamic testing in gynecological practice
- Department of Gynecology, „Inflancka” Specialist Hospital, Warsaw, Poland
- Cardinal Stefan Wyszynski University in Warsaw, Faculty of Medicine, Collegium Medicum, Warsaw, Poland
- Department of Obstetrics and Gynecology, Mother and Child Institute, Warsaw, Poland
- Department of Urology, Roefler Memorial Hospital, Pruszkow, Poland
- Department of Operative Gynecology and Gynecological Oncology, I Department of Gynecology and Obstetrics, Medical University of Lodz, Poland
- Department of Gynecology and Oncological Gynecology Military Institute of Medicine, Warsaw, Poland
- II Department of Gynecology, Medical University of Lublin, Poland
- Jagiellonian University Medical College, Department of Gynecology and Oncology, Cracow, Poland
- Department of Gynecology, Gynecological Oncology and Gynecological Endocrinology, Medical University of Gdansk, Poland
- Department of Gynecology and Obstetrics, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland
- II Department of Obstetrics and Gynecology Centre of Postgraduate Medical Education Bielański Hospital, Warsaw, Poland
open access
Abstract
Objectives: The aim was to present an interdisciplinary Guideline of the Urogynecology Section of the Polish Society of Gynecologists and Obstetricians (PSGO) for the use of urodynamics (UDS) in the diagnostic process of patients with lower urinary tract symptoms (LUTS) based on the available literature, expert knowledge, and everyday practice. Material and methods: A review of the literature concerning the use of UDS in women, including current international guidelines and earlier recommendations of the PSGO Urogynecology Section, was conducted. Results: Urodynamic testing allows to make the urodynamic diagnosis which, nevertheless, remains to be the preliminary diagnosis. Medical history, physical examination, and detailed analysis of the previous test results (laboratory, imaging, endoscopic) need to be taken into consideration before making the final diagnosis. Urodynamic testing before surgical treatment of SUI is allowable, but the decision remains at the discretion of the physician. Urodynamic testing is not necessary before primary surgical treatment of uncomplicated SUI, but it has been demonstrated to optimize the therapeutic methods in complicated SUI. The significance of UDS in the diagnostic process of patients with overactive bladder symptoms, voiding dysfunction, and bladder outlet obstruction was discussed. Conclusions: Urodynamic testing is a vital element of the urogynecological diagnostic process. The scope of UDS should reflect the individual needs and symptoms of each patient and be based on the current guidelines, expert knowledge and experience of the physician, indications, and eligibility, as well as additional test results of the affected patients. Due to formal and legal requirements, PSGO, in this Guideline, wishes to emphasize the need for an individualized approach to both, test performance and result interpretation.
Abstract
Objectives: The aim was to present an interdisciplinary Guideline of the Urogynecology Section of the Polish Society of Gynecologists and Obstetricians (PSGO) for the use of urodynamics (UDS) in the diagnostic process of patients with lower urinary tract symptoms (LUTS) based on the available literature, expert knowledge, and everyday practice. Material and methods: A review of the literature concerning the use of UDS in women, including current international guidelines and earlier recommendations of the PSGO Urogynecology Section, was conducted. Results: Urodynamic testing allows to make the urodynamic diagnosis which, nevertheless, remains to be the preliminary diagnosis. Medical history, physical examination, and detailed analysis of the previous test results (laboratory, imaging, endoscopic) need to be taken into consideration before making the final diagnosis. Urodynamic testing before surgical treatment of SUI is allowable, but the decision remains at the discretion of the physician. Urodynamic testing is not necessary before primary surgical treatment of uncomplicated SUI, but it has been demonstrated to optimize the therapeutic methods in complicated SUI. The significance of UDS in the diagnostic process of patients with overactive bladder symptoms, voiding dysfunction, and bladder outlet obstruction was discussed. Conclusions: Urodynamic testing is a vital element of the urogynecological diagnostic process. The scope of UDS should reflect the individual needs and symptoms of each patient and be based on the current guidelines, expert knowledge and experience of the physician, indications, and eligibility, as well as additional test results of the affected patients. Due to formal and legal requirements, PSGO, in this Guideline, wishes to emphasize the need for an individualized approach to both, test performance and result interpretation.
Keywords
urodynamics, stress urinary incontinence, overactive bladder, voiding dysfunction, bladder outlet obstruction, guidelines
Title
The Urogynecology Section of the Polish Society of Gynecologists and Obstetricians Guideline on the use of urodynamic testing in gynecological practice
Journal
Issue
Article type
Guidelines / Expert consensus
Pages
230-235
Published online
2021-03-31
Page views
1494
Article views/downloads
998
DOI
Pubmed
Bibliographic record
Ginekol Pol 2021;92(3):230-235.
Keywords
urodynamics
stress urinary incontinence
overactive bladder
voiding dysfunction
bladder outlet obstruction
guidelines
Authors
Artur Rogowski
Bartosz Dybowski
Edyta Wlazlak
Wlodzimierz Baranowski
Tomasz Rechberger
Klaudia Stangel-Wojcikiewicz
Magdalena E. Grzybowska
Tomasz Kluz
Elzbieta Narojczyk-Swiesciak
Monika Szafarowska
Zofia Rozpendowska
Grzegorz Surkont